Brain-Derived Neurotrophic Factor Modulates Nociceptive Sensory Inputs and NMDA-Evoked Responses in the Rat Spinal Cord

Central sensitization, the hyperexcitability of spinal processing that often accompanies peripheral injury, is a major component of many persistent pain states. Here we report that the neurotrophin, brain-derived neurotrophic factor (BDNF), is a modulator of excitability within the spinal cord and contributes to the mechanism of central sensitization. BDNF, localized in primary sensory neuron cell bodies and central terminals, potentiates nociceptive spinal reflex responses in an in vitro spinal cord preparation and induces c-fos expression in dorsal horn neurons. NMDA receptor-mediated responses, known as a major contributor to central sensitization, were significantly enhanced by exogenous BDNF. Systemic NGF treatment, a procedure that mimics peripheral inflammatory states, raises BDNF levels in sensory neurons and increases nociceptive spinal reflex excitability. This increased central excitability is reduced by trkB-IgG, a BDNF “antagonist.” We also show directly that inflammatory pain-related behavior depends on BDNF release in vivo. Thus behavioral nociceptive responses induced by intraplantar formalin and by intraplantar carageenan are significantly attenuated by trkB-IgG. Hence BDNF is appropriately localized and regulated in inflammatory states and is sufficient and necessary for the expression of central sensitization in the spinal cord. We propose that BDNF may function as a modulator of central sensitization in pathological states, and our results suggest that pharmacological antagonism of BDNF may prove an effective and novel analgesic strategy for the treatment of persistent inflammatory pain states.

[1]  B. Lu,et al.  Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus , 1996, Nature.

[2]  I. Black,et al.  Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Schuman,et al.  Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus , 1995, Science.

[4]  S. McMahon,et al.  The role of nerve growth factor in a model of visceral inflammation , 1997, Neuroscience.

[5]  Y. Barde,et al.  Physiology of the neurotrophins. , 1996, Annual review of neuroscience.

[6]  H. Cho,et al.  Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation , 1997, Brain Research.

[7]  Clifford J. Woolf,et al.  The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states , 1991, Pain.

[8]  M. Cousins.  International association for the study of pain , 1989, Pain.

[9]  C. Woolf,et al.  Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity , 1994, Neuroscience.

[10]  P. Seeburg,et al.  Subtype‐specific regulation of recombinant NMDA receptor‐channels by protein tyrosine kinases of the src family. , 1996, The Journal of physiology.

[11]  S. McMahon,et al.  Neurotrophic factors and pain , 1997 .

[12]  M. Palkovits,et al.  Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Gerber,et al.  Long duration ventral root potentials in the neonatal rat spinal cord in vitro; the effects of ionotropic and metabotropic excitatory amino acid receptor antagonists , 1992, Brain Research.

[14]  C. Stein,et al.  Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo , 1992, Neuroscience.

[15]  G. Michael,et al.  Nerve Growth Factor Treatment Increases Brain-Derived Neurotrophic Factor Selectively in TrkA-Expressing Dorsal Root Ganglion Cells and in Their Central Terminations within the Spinal Cord , 1997, The Journal of Neuroscience.

[16]  S. McMahon,et al.  Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones , 1995, Pain.

[17]  L. Urbán,et al.  Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat , 1995, Pain.

[18]  J. Gurd,et al.  Tyrosine phosphorylation of glycoproteins in the adult and developing rat brain , 1994, Journal of neuroscience research.

[19]  G. Mealing,et al.  Brain derived neurotrophic factor induction of N-methyl-D-aspartate receptor subunit NR2A expression in cultured rat cortical neurons , 1998, Neuroscience Letters.

[20]  I. Black,et al.  Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Woolf,et al.  Generation of acute pain: central mechanisms. , 1991, British medical bulletin.

[22]  Takayoshi Suzuki,et al.  NMDA Receptor Subunits ϵ1 (NR2A) and ϵ2 (NR2B) Are Substrates for Fyn in the Postsynaptic Density Fraction Isolated from the Rat Brain , 1995 .

[23]  Li Chen,et al.  Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation , 1992, Nature.

[24]  W. Snider,et al.  Nerve Growth Factor Regulates the Expression of Brain-Derived Neurotrophic Factor mRNA in the Peripheral Nervous System , 1996, Molecular and Cellular Neuroscience.

[25]  S. Apfel.  Neurotrophic Factors and Pain , 2000, The Clinical journal of pain.

[26]  C. Woolf,et al.  Contribution of interleukin‐1β to the inflammation‐induced increase in nerve growth factor levels and inflammatory hyperalgesia , 1995, British journal of pharmacology.

[27]  S. McMahon,et al.  NGF but Not NT-3 or BDNF Prevents the A Fiber Sprouting into Lamina II of the Spinal Cord That Occurs Following Axotomy , 1996, Molecular and Cellular Neuroscience.

[28]  C. Flexner,et al.  The effect of systemically administered recombinant human nerve growth factor in healthy human subjects , 1994, Annals of neurology.

[29]  R. Rush,et al.  Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons , 1996, Neuroscience.

[30]  R. Clatterbuck,et al.  Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo , 1993, Neuron.

[31]  T Bonhoeffer,et al.  Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Reader,et al.  Functional Evidence that BDNF Is an Anterograde Neuronal Trophic Factor in the CNS , 1998, The Journal of Neuroscience.

[33]  C. Epstein,et al.  Primary afferent tachykinins are required to experience moderate to intense pain , 1998, Nature.

[34]  R. Melzack,et al.  The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  C. Woolf,et al.  Activity‐Dependent Changes in Rat Ventral Horn Neurons in vitro; Summation of Prolonged Afferent Evoked Postsynaptic Depolarizations Produce a D‐2‐Amino‐5‐Phosphonovaleric Acid Sensitive Windup , 1990, The European journal of neuroscience.

[36]  L. Urbán,et al.  Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  S. McMahon,et al.  Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets , 1994, Neuron.

[38]  S. McMahon.  NGF as a mediator of inflammatory pain. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[39]  L. Mendell,et al.  Peripheral and Central Mechanisms of NGF‐induced Hyperalgesia , 1994, The European journal of neuroscience.

[40]  L. Olson,et al.  Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family , 1990, Neuron.

[41]  S. Lipton,et al.  NMDA receptors: from genes to channels. , 1996, Trends in pharmacological sciences.

[42]  S. McMahon,et al.  The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule , 1995, Nature Medicine.

[43]  S. McMahon,et al.  Rapid increase of NGF, BDNF and NT‐3 mRNAs in inflamed bladder , 1998, Neuroreport.

[44]  B. MacVicar,et al.  Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons. , 1997, Journal of neurophysiology.

[45]  Ted Abel,et al.  Recombinant BDNF Rescues Deficits in Basal Synaptic Transmission and Hippocampal LTP in BDNF Knockout Mice , 1996, Neuron.

[46]  Yu Tian Wang,et al.  Regulation of NMDA receptors by tyrosine kinases and phosphatases , 1994, Nature.

[47]  P. Distefano,et al.  Axotomy Upregulates the Anterograde Transport and Expression of Brain-Derived Neurotrophic Factor by Sensory Neurons , 1998, The Journal of Neuroscience.

[48]  S. McMahon,et al.  NT‐3, but not BDNF, prevents atrophy and death of axotomized spinal cord projection neurons , 1998, The European journal of neuroscience.